Olaratumab is a monoclonal antibody which is being developed by Imclone for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
